ESTRO 2024 - Abstract Book

S583

Clinical - Breast

ESTRO 2024

Material/Methods:

Patient data were retrospectively collected from January 2014 to June 2023. Characteristics of pts, brain metastases and treatment were recorded. Toxic effects were scored according to Common Terminology Criteria for Adverse Events (CTCAE v5.0). Statistical analysis of overall survival from intracranial RT (OS), Progression-free survival from intracranial RT (PFS) and local control of treated brain metastasis were performed by the Kaplan Meier method.

Results: